Hematologic Oncology Update CAR T-Cell and Bispecific Therapy for Lymphoma — Part 3 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
Jan 16, 2025
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10 11 12 13
Intro
00:00 • 2min
Exploring CAR T-Cell Therapy for DLBCL
02:05 • 4min
Navigating Complications and Treatment Options in Large Cell Lymphoma
05:46 • 3min
Treatment Options in Advanced Lymphoma: CAR T-Cell vs. Bispecific Antibodies
08:41 • 3min
Assessing CAR T-Cell Therapy Eligibility in Older Patients
11:52 • 2min
Navigating Challenges in CAR T-Cell Therapy
13:32 • 22min
Navigating Next Steps in Lymphoma Treatment
35:52 • 16min
Navigating Follicular Lymphoma Treatment
52:02 • 5min
Complex Cases in CNS Lymphoma Treatment
57:08 • 8min
Advancements in Lymphoma Treatment
01:05:12 • 20min
Management Strategies for Low Tumor Burden Follicular Lymphoma Relapses
01:25:33 • 2min
Advancements in Lymphoma Treatment Strategies
01:27:18 • 14min
Toxicities of CAR T-Cell Therapy and Bispecific Antibodies
01:41:40 • 19min